肝胆相照论坛

标题: 核心蛋白定向抗病毒药物和导入蛋白 β 可以协同破坏 HBV 衣 [打印本页]

作者: StephenW    时间: 2021-10-29 17:43     标题: 核心蛋白定向抗病毒药物和导入蛋白 β 可以协同破坏 HBV 衣

核心蛋白定向抗病毒药物和导入蛋白 β 可以协同破坏 HBV 衣壳
Christine Kim 1,Lauren F Barnes 2,Christopher J Schlicksup 1,Angela J Patterson 3,Brian B Bothner 3,Martin F Jarrold 2,Che-Yen Joseph Wang 4,Adam Zlotnick 1
隶属关系
隶属关系

    1
    美国印第安纳州布卢明顿印第安纳大学分子与细胞生物化学系。
    2
    美国印第安纳州布卢明顿印第安纳大学化学系。
    3
    美国蒙大拿州博兹曼蒙大拿州立大学化学与生物化学系。
    4
    宾夕法尼亚州立大学医学院微生物学和免疫学系,美国宾夕法尼亚州赫尔希。

    PMID:34705562 DOI:10.1128/JVI.01395-21

抽象的

病毒结构蛋白可以具有多种活性。靶向结构蛋白的抗病毒药物有可能表现出多种抗病毒机制。乙型肝炎病毒 (HBV) 核心蛋白 (Cp) 参与病毒生命周期的大多数阶段:它组装成衣壳,包装病毒 RNA,是逆转录的代谢区室,与核运输机制相互作用,并分解以释放病毒基因组进入细胞核。在核定位期间,HBV 衣壳通过 Cp 的 C 端结构域 (CTD) 与宿主输入蛋白(例如 Impβ)结合; CTD 位于衣壳内部,并暂时暴露在外部。我们使用 HAP12 作为代表性的 Cp 变构调节剂 (CpAMs),这是一类不恰当地刺激和误导 HBV 组装并使衣壳变形的抗病毒药物。 CpAM 对 HBV 生命周期其他方面的影响知之甚少。我们在体外研究了 HAP12 如何影响空的或 RNA 填充的衣壳与 Impβ 和胰蛋白酶之间的相互作用。我们表明 HAP12 可以调节 CTD 可及性和衣壳稳定性,这取决于 HAP12 结合位点的饱和度。我们证明了 Impβ 在高 HAP12 饱和度下协同促进衣壳破坏,使用电子显微镜观察 Cp 二聚体的破坏和重排成异常复合物。然而,RNA 填充的衣壳抵抗了 HAP12 和 Impβ 的不稳定效应。总之,我们展示了宿主蛋白诱导的衣壳破坏催化作用,这是 CpAM 的一种意想不到的额外作用机制。不合时宜的衣壳分解可能会阻碍 HBV 的生命周期,并导致病毒变得容易受到宿主先天免疫反应的影响。重要性 HBV 核心是 120 个拷贝的同源二聚体核心(衣壳)蛋白的二十面体复合物,带有或不带有包装的核酸,通过与宿主输入蛋白的相互作用被转运到宿主细胞核。导入蛋白-核心相互作用需要衣壳内部的核心蛋白 C 端结构域“翻转”到衣壳外部。最近开发了影响衣壳组装和稳定性的核心蛋白定向药物。我们表明,这些分子可以与输入蛋白协同作用,破坏衣壳。这种与宿主蛋白协同作用的作用机制有可能破坏病毒生命周期并激活先天免疫系统。
作者: StephenW    时间: 2021-10-29 17:43

Core Protein-Directed Antivirals and Importin β Can Synergistically Disrupt HBV Capsids
Christine Kim  1 , Lauren F Barnes  2 , Christopher J Schlicksup  1 , Angela J Patterson  3 , Brian B Bothner  3 , Martin F Jarrold  2 , Che-Yen Joseph Wang  4 , Adam Zlotnick  1
Affiliations
Affiliations

    1
    Department of Molecular & Cellular Biochemistry, Indiana University, Bloomington, Indiana, USA.
    2
    Department of Chemistry, Indiana University, Bloomington, Indiana, USA.
    3
    Department of Chemistry & Biochemistry, Montana State University, Bozeman, Montana, USA.
    4
    Department of Microbiology & Immunology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.

    PMID: 34705562 DOI: 10.1128/JVI.01395-21

Abstract

Viral structural proteins can have multiple activities. Antivirals that target structural proteins have potential to exhibit multiple antiviral mechanisms. Hepatitis B Virus (HBV) core protein (Cp) is involved in most stages of the viral lifecycle: it assembles into capsids, packages viral RNA, is a metabolic compartment for reverse transcription, interacts with nuclear trafficking machinery, and disassembles to release the viral genome into the nucleus. During nuclear localization, HBV capsids bind to host importins (e.g. Impβ) via Cp's C-terminal domain (CTD); the CTD is localized to the interior of the capsid and is transiently exposed on the exterior. We used HAP12 as a representative Cp Allosteric Modulators (CpAMs), a class of antivirals that inappropriately stimulates and misdirects HBV assembly and deforms capsids. CpAM impact on other aspects of the HBV lifecycle is poorly understood. We investigated how HAP12 influenced the interactions between empty or RNA-filled capsids with Impβ and trypsin in vitro. We showed that HAP12 can modulate CTD accessibility and capsid stability, depending on the saturation of HAP12-binding sites. We demonstrated that Impβ synergistically contributes to capsid disruption at high levels of HAP12 saturation, using electron microscopy to visualize disruption and rearrangement of Cp dimers into aberrant complexes. However, RNA-filled capsids resisted the destabilizing effects of HAP12 and Impβ. In summary, we show host protein-induced catalysis of capsid disruption, an unexpected additional mechanism of action for CpAMs. Potentially, untimely capsid disassembly can hamper the HBV lifecycle and also cause the virus to become vulnerable to host innate immune responses. IMPORTANCE The HBV core, an icosahedral complex of 120 copies of the homodimeric core (capsid) protein with or without packaged nucleic acid, is transported to the host nucleus by its interaction with host importin proteins. Importin-core interaction requires the core protein C-terminal domain, which is inside the capsid, to "flip" to the capsid exterior. Core-protein directed drugs that affect capsid assembly and stability have been developed recently. We show that these molecules can, synergistically with importins, disrupt capsids. This mechanism of action, synergism with host protein, has potential to disrupt the virus lifecycle and activate the innate immune system.

作者: StephenW    时间: 2021-10-29 17:44

https://www.biorxiv.org/content/10.1101/2021.08.16.456586v1
作者: lancas    时间: 2021-10-29 18:41


作者: newchinabok    时间: 2021-10-29 18:58

本帖最后由 newchinabok 于 2021-10-29 18:59 编辑

这辈子能看到功能性治愈就知足了。其它不想了




欢迎光临 肝胆相照论坛 (http://hbvhbv.info/forum/) Powered by Discuz! X1.5